175 related articles for article (PubMed ID: 23700827)
21. Congenital thrombotic thrombocytopenic purpura with novel mutations in three unrelated Turkish children.
Metin A; Unal S; Gümrük F; Palla R; Cairo A; Underwood M; Gurgey A
Pediatr Blood Cancer; 2014 Mar; 61(3):558-61. PubMed ID: 24115559
[TBL] [Abstract][Full Text] [Related]
22. Remission of thrombotic thrombocytopenic purpura in a patient with compound heterozygous deficiency of von Willebrand factor-cleaving protease by infusion of solvent/detergent plasma.
Kentouche K; Budde U; Furlan M; Scharfe V; Schneppenheim R; Zintl F
Acta Paediatr; 2002; 91(10):1056-9. PubMed ID: 12434890
[TBL] [Abstract][Full Text] [Related]
23. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
Furlan M; Lämmle B
Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
[TBL] [Abstract][Full Text] [Related]
24. Dissociation between the level of von Willebrand factor-cleaving protease activity and disease in a patient with congenital thrombotic thrombocytopenic purpura.
Snider CE; Moore JC; Warkentin TE; Finch CN; Hayward CP; Kelton JG
Am J Hematol; 2004 Dec; 77(4):387-90. PubMed ID: 15551280
[TBL] [Abstract][Full Text] [Related]
25. Role of ADAMTS13 in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura.
Kremer Hovinga JA; Lämmle B
Hematology Am Soc Hematol Educ Program; 2012; 2012():610-6. PubMed ID: 23233642
[TBL] [Abstract][Full Text] [Related]
26. [New marker in thrombotic thrombocytopenic purpura].
Gøtze JP; Hillarp A; Lindblom A; Björk P; Strandberg K; Nielsen LB
Ugeskr Laeger; 2008 Aug; 170(33):2446-9. PubMed ID: 18761827
[TBL] [Abstract][Full Text] [Related]
27. [Activity loss of Von Willebrand factor cleaving protein (ADAMTS-13) is diagnostic for primary and pregnancy-related thrombotic thrombocytopenic purpura].
Hulstein JJ; Rison CN; Kappers-Klunne MC; Hene RJ; Franx A; de Groot PG; Brand A; Fijnheer R
Ned Tijdschr Geneeskd; 2004 Oct; 148(40):1972-6. PubMed ID: 15524133
[TBL] [Abstract][Full Text] [Related]
28. Thrombotic thrombocytopenic purpura in children.
Loirat C; Coppo P; Veyradier A
Curr Opin Pediatr; 2013 Apr; 25(2):216-24. PubMed ID: 23422353
[TBL] [Abstract][Full Text] [Related]
29. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
[TBL] [Abstract][Full Text] [Related]
30. ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura.
Zheng XL
Annu Rev Med; 2015; 66():211-25. PubMed ID: 25587650
[TBL] [Abstract][Full Text] [Related]
31. [ADAMTS13, von Willebrand factor specific cleaving protease].
Veyradier A; Coppo P
Med Sci (Paris); 2011 Dec; 27(12):1097-105. PubMed ID: 22192749
[TBL] [Abstract][Full Text] [Related]
32. [TTP/HUS and VWF/ADAMTS-13].
Fujimura Y
Rinsho Ketsueki; 2003 Dec; 44(12):1144-53. PubMed ID: 14978930
[No Abstract] [Full Text] [Related]
33. ADAMTS-13 regulates platelet adhesion under flow. A new method for differentiation between inherited and acquired thrombotic thrombocytopenic purpura.
Shenkman B; Budde U; Angerhaus D; Lubetsky A; Savion N; Seligsohn U; Varon D
Thromb Haemost; 2006 Aug; 96(2):160-6. PubMed ID: 16894459
[TBL] [Abstract][Full Text] [Related]
34. Ten years of prophylactic treatment with fresh-frozen plasma in a child with chronic relapsing thrombotic thrombocytopenic purpura as a result of a congenital deficiency of von Willebrand factor-cleaving protease.
Barbot J; Costa E; Guerra M; Barreirinho MS; Isvarlal P; Robles R; Gerritsen HE; Lämmle B; Furlan M
Br J Haematol; 2001 Jun; 113(3):649-51. PubMed ID: 11380451
[TBL] [Abstract][Full Text] [Related]
35. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.
Tsai HM
J Mol Med (Berl); 2002 Oct; 80(10):639-47. PubMed ID: 12395148
[TBL] [Abstract][Full Text] [Related]
36. [Clinical features and laboratory findings of thrombotic thrombocytopenic purpura associated with ticlopidine].
Yagi H
Rinsho Byori; 2005 Jul; 53(7):630-8. PubMed ID: 16104532
[TBL] [Abstract][Full Text] [Related]
37. [Hereditary hemolytic uremic syndromes and thrombotic thrombocytopenic purpura].
Loirat C; Sellier-Leclerc AL; Frémeaux-Bacchi V; Dragon-Durey A; Girma JP; Veyradier A
Nephrol Ther; 2006 Jan; 2 Suppl 2():S149-61. PubMed ID: 17373216
[TBL] [Abstract][Full Text] [Related]
38. Hypersensitivity to plasma exchange in a patient with thrombotic thrombocytopenic purpura.
Lalmuanpuii J; Yalamanchili K; Fircanis S; Nelson JC
J Clin Apher; 2009; 24(1):18-20. PubMed ID: 19073012
[TBL] [Abstract][Full Text] [Related]
39. Hereditary thrombotic purpura.
Khan MR; Ashraf MS
J Pak Med Assoc; 2014 Feb; 64(2):217-9. PubMed ID: 24640819
[TBL] [Abstract][Full Text] [Related]
40. [Successful delivery following treatment with plasma exchange in a female patient with thrombotic thrombocytopenic purpura].
Takagi Y; Adachi Y; Tsujimura A; Tsushita K
Rinsho Ketsueki; 2012 Aug; 53(8):770-3. PubMed ID: 22975818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
